Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

UK pre-market stocks update – Unilever, GSK, Taylor Wimpey, AstraZeneca

Stock MarketsJan 17, 2022 07:38
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters.

By Samuel Indyk – At 07:34GMT, FTSE 100 futures are trading higher by 0.1% at 7505.

In FX markets, GBP/USD is trading at 1.3681, EUR/GBP is trading at 0.8352. The US Dollar Index is flat.

Bitcoin is trading at $42,819.

Today’s calendar highlights include Bundesbank monthly report, Canadian Manufacturing Sales.


Unilever (LON:ULVR) / GlaxoSmithKline (LON:GSK) - Unilever confirms it has approached GSK and Pfizer (NYSE:PFE) about a potential acquisition of the GSK Consumer Healthcare unit. The latest proposal was for a total acquisition value of £50 billion, comprising £41.7 billion in cash and £8.3 billion in Unilever shares. GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects.

Unilever - As a result of the reporting of interest in GSK’s Consumer Health unit, Unilever has brought forward a planned strategic update. Unilever said its future strategic direction lies in materially expanding its presence in Health, Beauty, and Hygiene. The board concluded that major acquisitions should be accompanied by the accelerated divestment of intrinsically lower growth brands and businesses.

Taylor Wimpey (LON:TW) - 2021 total UK home completions increased by 47% to 14,087. Net private reservation rate for 2021 was 0.91 homes per outlet per week (2020: 0.76). Average selling prices on private completions increased by 3% to £332k (2020: £323k), with the overall average selling price increasing to £300k (2020: £288k).  Will announce the level of excess cash return in respect of 2021 with the company's full year results on 3 March 2022. 47% forward sold for 2022 (2021: 54%). Confident in achieving primary performance target to return the business to a 21-22% operating margin.

AstraZeneca (LON:AZN) - Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen.

Ashmore (LON:ASHM) - Total assets under management estimated at 31st December 2021 fell 4.4% from September to $87.3 billion. Assets under management declined by $4.0 billion over the period, comprising net outflows of $2.2 billion and negative investment performance of $1.8 billion.

Hikma Pharmaceuticals (LON:HIK) - Agreed to acquire the Canadian assets of Teligent for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022.

Oxford BioMedica (LON:OXB) - Chief Executive Officer John Dawson has signalled to the Board his intention to retire from the Company. Accordingly, the Board has initiated a formal search for a successor.

Qinetiq (LON:QQ) - Names Shawn Purvis as President and CEO of QinetiQ US, effective 16th February.

Capital & Counties Properties (LON:CAPCC) - As at 31 December 2021, the independent property valuation of Covent Garden was £1.7 billion, representing a like-for-like increase of 4.6% in the second half of the year and an overall movement of -0.6% for the full year. Rent collection in relation to the first quarter of 2022, invoiced in December 2021, is currently 86%.

Tritax EuroBox (LON:EBOX) - Completed the acquisition of the land and agreed to fund the development of a 17,832 sqm prime sustainable logistics asset in Sweden for SEK 402 million.

Big Yellow Group (LON:BYG) - Q3 total revenue increased 30% to £45.2 million. Occupancy across all 104 stores decreased by 245,000 sq ft compared to a loss of 193,000 sq ft in 2019. Move-outs were higher over this quarter than in 2019, reflective of a record first quarter's occupancy gain leading up to the tapering off of the stamp duty holiday.

Endeavour Mining (LON:EDV) - Announced the discovery of 3.0 million ounces of Measured and Indicated resources and 0.9 million ounces of Inferred resources across its flagship Ity, Houndé and Sabodala-Massawa mines as well as at its Lafigué deposit on the Fetekro property.

Micro Focus (LON:MCRO) - Announced that it has successfully priced and allocated a €750 million and a $750 million Senior Secured Term Loan B.

Clinigen (LON:CLINC) - Agrees to be taken over by Triton in a deal worth 925 pence per share.

ASOS (LON:ASOS) - Former Farfetch executive Andrew Robb is reportedly among candidates for CEO position at ASOS (LON:ASOS). (Sky News)

Darktrace (LON:DARK) - Short seller ShadowFall has launched a short attack on Darktrace as it doubts the company “will stand the test of time”.

UK pre-market stocks update – Unilever, GSK, Taylor Wimpey, AstraZeneca

Related Articles

Cryptoverse: Is the end of the bitcoin winter nigh?
Cryptoverse: Is the end of the bitcoin winter nigh? By Reuters - May 24, 2022 1

By Medha Singh and Lisa Pauline Mattackal (Reuters) - The crypto winter is into its ninth week and bitcoin can't shake the chills. From technicals to turnover, market indicators...

Caleres Shares Surge 8% on Q1 Earnings Beat and Raise
Caleres Shares Surge 8% on Q1 Earnings Beat and Raise By - May 24, 2022

By Davit Kirakosyan Caleres (NYSE:CAL) shares surged around 8% after-hours following the company's reported Q1 results, with EPS of $1.32 coming in above the consensus estimate of...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Soe gyi
Soe gyi Jan 17, 2022 11:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
Sign up with Email